Research Study

A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The Prime Study
Principal Investigator 
Alan I. So

Overview

Body Locations and Systems 
Prostate Cancer
Disorders and Conditions 
Metabolic Problems
ClinicalTrials.gov# 
NCT03031821
Status 
Recruiting
Study Start/End 
Jun 21, 2018
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Sarah Charlesworth, Research Coordinator
Phone 
604-875-4111 x67898
Purpose of Study 

The purpose of this study is to determine if there are differences between patients who receive metformin or placebo with respect to the proportion of patients who meet the diagnostic criteria for metabolic syndrome after 18 months of study treatment.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.